Patrick F. Kelly M.D.
Net Worth
Last updated:
What is Patrick F. Kelly M.D. net worth?
The estimated net worth of Dr. Patrick F. Kelly M.D. is at least $4,626,065 as of 13 Apr 2022. He owns shares worth $1,298,329 as insider, has earned $51,286 from insider trading and has received compensation worth at least $3,276,450 in Forma Therapeutics Holdings, Inc..
What is the salary of Patrick F. Kelly M.D.?
Dr. Patrick F. Kelly M.D. salary is $655,290 per year as Senior Vice President & Chief Medical Officer in Forma Therapeutics Holdings, Inc..
How old is Patrick F. Kelly M.D.?
Dr. Patrick F. Kelly M.D. is 61 years old, born in 1964.
What stocks does Patrick F. Kelly M.D. currently own?
As insider, Dr. Patrick F. Kelly M.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Forma Therapeutics Holdings, Inc. (FMTX) | Senior Vice President & Chief Medical Officer | 64,884 | $20.01 | $1,298,329 |
What does Forma Therapeutics Holdings, Inc. do?
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobinopathies; and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company is also developing Olutasidenib, a selective inhibitor for cancers with isocitrate dehydrogenase 1 gene mutations, which is in Phase II trial for the treatment of relapsed/refractory acute myeloid leukemia and Phase I trial to treat glioma; and FT-8225, a liver-targeted fatty-acid synthase inhibitor designed to block de novo lipogenesis in the liver. Forma Therapeutics Holdings, Inc. was founded in 2007 and is headquartered in Watertown, Massachusetts. As of October 14, 2022, Forma Therapeutics Holdings, Inc. operates as a subsidiary of Novo Nordisk A/S.
Patrick F. Kelly M.D. insider trading
Forma Therapeutics Holdings, Inc.
Dr. Patrick F. Kelly M.D. has made 2 insider trades between 2020-2022, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 42,959 units of FMTX stock on 23 Jun 2020. As of 13 Apr 2022 he still owns at least 64,884 units of FMTX stock.
Forma Therapeutics Holdings key executives
Forma Therapeutics Holdings, Inc. executives and other stock owners filed with the SEC:
- Dr. Patrick F. Kelly M.D. (61) Senior Vice President & Chief Medical Officer
- Mr. Frank D. Lee (57) Pres, Chief Executive Officer & Director
- Mr. Todd E. Shegog (60) Senior Vice President & Chief Financial Officer